Breaking News
0

Pre-Open Movers: Amazon, Apple Gain on Results; Intel Plummets on Disappointment

Stock Markets Jul 29, 2022 09:22
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
CVX
+1.61%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
INTC
-0.45%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AAPL
+1.59%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AMZN
+0.53%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
XOM
+2.74%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
X
+2.50%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Pre-Open Stock Movers:

Roku (NASDAQ:ROKU) 26% LOWER; reported Q2 EPS of ($0.82), $0.14 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $764.4 million versus the consensus estimate of $804.13 million. Roku sees Q3 2022 revenue of $700 million, versus the consensus of $901.7 million.

DexCom (NASDAQ:DXCM8% LOWER; reported Q2 EPS of $0.17, $0.02 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $696.2 million versus the consensus estimate of $700.45 million. DexCom sees Q3 2022 revenue of $2.86 billion-2.91 billion, versus the consensus of $2.92 billion.

Amazon (NASDAQ:AMZN) 9% HIGHER; reported Q2 EPS of ($0.20), $0.33 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $121.2 billion versus the consensus estimate of $119.18 billion. Amazon sees Q3 2022 revenue of $125 billion-130 billion, versus the consensus of $126.4 billion.

Sarepta Therapeutics (NASDAQ:SRPT9% HIGHER; announced its intent to submit a Biologics License Application (BLA) seeking accelerated approval for SRP-9001 (delandistrogene moxeparvovec) to treat ambulant individuals with Duchenne muscular dystrophy. SRP-9001 is an investigational gene therapy for Duchenne being developed in partnership with Roche.

Intel (NASDAQ:INTC) 10% LOWER; reported Q2 EPS of $0.29, $0.41 worse than the analyst estimate of $0.70. Revenue for the quarter came in at $15.3 billion versus the consensus estimate of $17.96 billion. Intel sees FY2022 EPS of $2.30, versus the consensus of $3.42. Intel sees FY2022 revenue of $65 billion-68 billion, versus the consensus of $74.3 billion. Intel sees Q3 2022 EPS of $0.35, versus the consensus of $0.87. Intel sees Q3 2022 revenue of $15 billion-16 billion, versus the consensus of $18.62 billion.

Trade Desk (NASDAQ:TTD) 9% LOWER; TTD and Michelle Hulst, the Company’s Chief Data Officer, agreed that Ms. Hulst will step down from her current position effective as of July 29, 2022. Upon her departure from the Company, it is intended that Ms. Hulst receive the benefits provided for an employment termination without cause as set forth in her previously filed Employment Agreement dated January 11, 2021.

Five9 (NASDAQ:FIVN) 10% HIGHER; reported Q2 EPS of $0.34, $0.16 better than the analyst estimate of $0.18. Revenue for the quarter came in at $189.4 million versus the consensus estimate of $180.12 million. Five9 sees FY2022 EPS of $1.38-$1.40, versus the consensus of $1.22. Five9 sees FY2022 revenue of $780.5 million-782.5 million, versus the consensus of $772.1 million. Five9 sees Q3 2022 EPS of $0.31-$0.33, versus the consensus of $0.30. Five9 sees Q3 2022 revenue of $192.5 million-193.5 million, versus the consensus of $192.3 million.

Deckers Brands (NYSE:DECK) 8% HIGHER; reported Q1 EPS of $1.66, $0.41 better than the analyst estimate of $1.25. Revenue for the quarter came in at $614.5 million versus the consensus estimate of $567.34 million. The Board of Directors Approved Additional Share Repurchase Authorization of $1.2 billion. Deckers Brands sees FY2023 EPS of $17.50-$18.35, versus the consensus of $17.98. Deckers Brands sees FY2023 revenue of $3.45-3.5 million, versus the consensus of $3.49 million.

Edwards Lifesciences (NYSE:EW) 7% LOWER; reported Q2 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.4 billion. Edwards Lifesciences sees Q3 2022 EPS of $0.58-$0.66, versus the consensus of $0.65. Edwards Lifesciences sees Q3 2022 revenue of $1.3 billion-1.37 billion, versus the consensus of $1.44 billion.

U.S. Steel (NYSE:X) 2% HIGHER; reported Q2 EPS of $3.86, $0.36 better than the analyst estimate of $3.50. Revenue for the quarter came in at $6.29 billion versus the consensus estimate of $5.81 billion.

Chevron (NYSE:CVX) 4% HIGHER; reported Q2 EPS of $5.82, $0.73 better than the analyst estimate of $5.09. Revenue for the quarter came in at $68.76 billion versus the consensus estimate of $57.96 billion.

Apple (NASDAQ:AAPL) 3% HIGHER; reported Q3 EPS of $1.20, $0.04 better than the analyst estimate of $1.16. Revenue for the quarter came in at $83 billion versus the consensus estimate of $82.59 billion.

Procter & Gamble (NYSE:PG5% LOWER; reported Q4 EPS of $1.21, $0.02 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $19.5 billion versus the consensus estimate of $19.37 billion.

Exxon Mobil (NYSE:XOM) 2% HIGHER; reported Q2 EPS of $4.21, $0.37 better than the analyst estimate of $3.84. Revenue for the quarter came in at $115.68 billion versus the consensus estimate of $94.97 billion.

 
Pre-Open Movers: Amazon, Apple Gain on Results; Intel Plummets on Disappointment
 

Related Articles

Wall Street rebounds, sterling steadies after tumble
Wall Street rebounds, sterling steadies after tumble By Reuters - Sep 27, 2022

By Lawrence Delevingne and Carolyn Cohn (Reuters) - U.S. stocks opened higher and sterling bounced from this week's record lows against the dollar on Tuesday as investors took...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email